Clinical Trial Update: KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial update for KW-136 with Sofosbuvir in Chinese adults with chronic hepatitis C completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• KW-136 with Sofosbuvir

Snippet

Sponsor: Kawin Technology Share-holding Co., Ltd. | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED